Arthropathy and Back Pain

Your Symptom

Aching lower back — persistent. In context of C282Y/H63D compound heterozygosity, prior ferritin ~700 ug/L, and current TSAT 60%.

Pathogenesis Overview

flowchart TD
    A[HFE Iron Overload] --> B[Iron Deposition in Joints]
    B --> C[Chondrocyte Damage]
    B --> D[CPPD Crystal Nucleation]
    C --> E[Cartilage Degradation]
    D --> E
    E --> F[Secondary Osteoarthritis]
    B --> G[Synovial ROS Production]
    G --> C

    H[C282Y Homozygote - High Risk] --> A
    I[C282Y/H63D Compound Het - Moderate Risk] --> A

    J[MCP 2nd/3rd Joints] --- K[Sentinel Sign]
    F --> J

    classDef risk fill:#f1948a,stroke:#c0392b,color:#1a0505
    classDef mechanism fill:#85c1e9,stroke:#2471a3,color:#0a1929
    classDef outcome fill:#f7dc6f,stroke:#b7950b,color:#1a1400
    classDef sentinel fill:#6a9,stroke:#364,color:#000

    class H,I risk
    class B,C,D,G mechanism
    class E,F outcome
    class J,K sentinel

Haemochromatosis Arthropathy — Overview

Joint disease is one of the most common and earliest manifestations of genetic haemochromatosis. It often precedes diagnosis by years and can occur even in compound heterozygotes with modest iron loading.

Kiely PDW. "Haemochromatosis arthropathy — a conundrum of the Celtic curse." J R Coll Physicians Edinb. 2018;48(3):233-238

The Distinctive Pattern

Classic haemochromatosis arthropathy targets:

Hemochromatosis Arthropathy chapter — Springer, Kiely PDW. 2022

Does It Happen in Compound Heterozygotes?

Yes — though less studied than in C282Y homozygotes:

Toama W et al. "Iron study is a weak indicator in symptomatic C282Y/H63D compound heterozygotes." 2015

Camacho A et al. "Effect of C282Y genotype on self-reported musculoskeletal complications in hereditary hemochromatosis." PLoS One. 2015

UK Biobank Evidence

Banfield LR et al. "Hemochromatosis genetic variants and musculoskeletal outcomes: 11.5-year follow-up in the UK Biobank cohort study." JBMR Plus. 2023;7:e10794

Haemochromatosis UK Patient Guidance

"Many older people with genetic haemochromatosis experience arthropathy and associated acute joint pain... It is assumed that ongoing iron overload is the principal cause of joint damage, however this may not be the only explanation. Most patients find that removal of excess iron from the body makes little difference to joint stiffness or pain."
— haemochromatosis.org.uk/arthropathy

  1. Iron deposition in synovium and cartilage — direct chondrotoxicity
  2. Calcium pyrophosphate crystal deposition (CPPD) — iron promotes crystal nucleation
  3. Oxidative damage — iron-catalysed ROS in avascular cartilage
  4. Inflammatory cytokine activation — iron activates macrophages in joint tissue

Lower Back Specifically

Iron deposition in the spine is less studied than hands/wrists but documented:

Other Contributing Factors in Your Case

What to Discuss With Your Doctor

  1. X-ray of lumbar spine and hands — look for haemochromatosis-pattern changes (hook-like osteophytes at MCPs, disc/facet changes in spine)
  2. MRI lumbar spine if X-ray shows changes or pain persists
  3. Calcium pyrophosphate screening — synovial fluid analysis if any acute flares
  4. Whether iron reduction might slow progression — evidence is mixed but early intervention may help more than late

Important Caveat

Joint damage from iron overload may be irreversible even after de-ironing. This is one of the strongest arguments for early and proactive iron management in your case, despite the "low risk" genotype label.

Key References

  1. Kiely PDW. Haemochromatosis arthropathy. J R Coll Physicians Edinb. 2018;48(3):233-238
  2. Kiely PDW. Hemochromatosis Arthropathy (Springer chapter). 2022;pp.111-123
  3. Banfield LR et al. HH genetic variants and musculoskeletal outcomes. JBMR Plus. 2023;7:e10794
  4. Camacho A et al. C282Y genotype and musculoskeletal complications. PLoS One. 2015
  5. Toama W et al. Iron study is a weak indicator in symptomatic compound hets. 2015
  6. Haemochromatosis UK. Arthropathy and joint pain. haemochromatosis.org.uk
  7. Mayo Clinic. Hemochromatosis — symptoms and causes. 2026

Cross-References